Performance

BCRX +7.62%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
BCRX	-0.78%	-2.18%	+7.62%	-9.25%	-31.32%	0.31	0.00%

Summary

BCRX at a glance

BCRX returned +7.62% over the past year and -9.25% a year over five years. Its worst drop in that year was -31.32%, smaller than 55% of stocks on Redstone, and its Sharpe ratio of 0.31 beats 42% of stocks on Redstone. It pays no dividends.

Ranking

How BCRX ranks

Current Drawdown

-31.32%

Rolling Volatility

45.07%

Actions

Metrics

Risk Indicators

Alpha8.44%

Beta0.68x

Sharpe0.31

Sortino0.49

Omega1.05

Calmar0.24

Martin1.06

Profile

About BCRX

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases.

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $2.0B
Listed: Mar 1994
Employees: 435
Headquarters: Durham, NC
Website: biocryst.com

Comparisons

BCRX: BioCryst Pharmaceuticals, Inc.

BCRX at a glance

How BCRX ranks

Current Drawdown

Rolling Volatility

About BCRX

Related comparisons